256
Views
67
CrossRef citations to date
0
Altmetric
Original Research

Pristimerin protects against doxorubicin-induced cardiotoxicity and fibrosis through modulation of Nrf2 and MAPK/NF-kB signaling pathways

, , , , , & show all
Pages 47-61 | Published online: 19 Dec 2018

References

  • ThornCFOshiroCMarshSDoxorubicin pathways: pharmacodynamics and adverse effectsPharmacogenet Genomics201121744044621048526
  • CarvalhoFSBurgeiroAGarciaRMorenoAJCarvalhoRAOliveiraPJDoxorubicin-induced cardiotoxicity: from bioenergetic failure and cell death to cardiomyopathyMed Res Rev201434110613523494977
  • IvanováMDovinováIOkruhlicováLChronic cardiotoxicity of doxorubicin involves activation of myocardial and circulating matrix metalloproteinases in ratsActa Pharmacol Sin201233445946922447222
  • OctaviaYTocchettiCGGabrielsonKLJanssensSCrijnsHJMoensALDoxorubicin-induced cardiomyopathy: from molecular mechanisms to therapeutic strategiesJ Mol Cell Cardiol20125261213122522465037
  • SchunkeKJCoyleLMerrillGFDenhardtDTAcetaminophen attenuates doxorubicin-induced cardiac fibrosis via osteopontin and GATA4 regulation: reduction of oxidant levelsJ Cell Physiol2013228102006201423526585
  • LiuGLiuYWangRSpironolactone attenuates doxorubicin-induced cardiotoxicity in ratsCardiovasc Ther201634421622427097055
  • MaQRole of nrf2 in oxidative stress and toxicityAnnu Rev Pharmacol Toxicol20135340142623294312
  • WangLFSuSWWangLTert-butylhydroquinone ameliorates doxorubicin-induced cardiotoxicity by activating Nrf2 and inducing the expression of its target genesAm J Transl Res20157101724173526692920
  • HajraSBasuASingha RoySPatraARBhattacharyaSAttenuation of doxorubicin-induced cardiotoxicity and genotoxicity by an indole-based natural compound 3,3’-diindolylmethane (DIM) through activation of Nrf2/ARE signaling pathways and inhibiting apoptosisFree Radic Res2017519–1081282728922986
  • NozakiNShishidoTTakeishiYKubotaIModulation of doxorubicin-induced cardiac dysfunction in toll-like receptor-2-knockout miceCirculation2004110182869287415505089
  • FouadAAAlbualiWHAl-MulhimASJresatICardioprotective effect of cannabidiol in rats exposed to doxorubicin toxicityEnviron Toxicol Pharmacol201336234735723721741
  • SaeedNMEl-NagaRNEl-BaklyWMAbdel-RahmanHMSalah EldinRAEl-DemerdashEEpigallocatechin-3-gallate pretreatment attenuates doxorubicin-induced cardiotoxicity in rats: A mechanistic studyBiochem Pharmacol201595314515525701654
  • El-AgamyDSAbo-HadedHMElkablawyMACardioprotective effects of sitagliptin against doxorubicin-induced cardiotoxicity in ratsExp Biol Med20162411415771587
  • CostaPMFerreiraPMBolzaniVSAntiproliferative activity of pristimerin isolated from Maytenus ilicifolia (Celastraceae) in human HL-60 cellsToxicol In Vitro200822485486318296021
  • TongLNanjundaiahSMVenkateshaSHAstryBYuHMoudgilKDPristimerin, a naturally occurring triterpenoid, protects against autoimmune arthritis by modulating the cellular and soluble immune mediators of inflammation and tissue damageClin Immunol2014155222023025308129
  • DeebDGaoXLiuYBPindoliaKGautamSCPristimerin, a qui-nonemethide triterpenoid, induces apoptosis in pancreatic cancer cells through the inhibition of pro-survival Akt/NF-kB/mTOR signaling proteins and anti-apoptotic Bcl-2Int J Oncol20144451707171524603988
  • El-AgamyDSShaabanAAAlmaramhyHHElkablawySElkablawyMAPristimerin as a novel hepatoprotective agent against experimental autoimmune hepatitisFront Pharmacol2018929229643811
  • ArafaMHMohammadNSAtteiaHHAbd-ElazizHRProtective effect of resveratrol against doxorubicin-induced cardiac toxicity and fibrosis in male experimental ratsJ Physiol Biochem201470370171124939721
  • VargheseFBukhariABMalhotraRDeAIHC Profiler: an open source plugin for the quantitative evaluation and automated scoring of immunohistochemistry images of human tissue samplesPLoS One201495e9680124802416
  • Abo-HadedHMElkablawyMAAl-JohaniZAl-AhmadiOEl-AgamyDSHepatoprotective effect of sitagliptin against methotrexate induced liver toxicityPLoS One2017123e017429528334048
  • PeiXMYungBYYipSPYingMBenzieIFSiuPMDesacyl ghrelin prevents doxorubicin-induced myocardial fibrosis and apoptosis via the GHSR-independent pathwayAm J Physiol Endocrinol Metab20143063E311E32324326424
  • WuXQiXLuYLiguzinediol protects against cardiac fibrosis in rats in vivo and in vitroBiomed Pharmacother20168026026727133065
  • ElsherbinyNMSalamaMFSaidEEl-SherbinyMAl-GayyarMMCrocin protects against doxorubicin-induced myocardial toxicity in rats through down-regulation of inflammatory and apoptic pathwaysChem Biol Interact2016247394826807765
  • Martinel LamasDJNicoudMBSterleHASelective cytoprotective effect of histamine on doxorubicin-induced hepatic and cardiac toxicity in animal modelsCell Death Discov201511505927551485
  • EzzatSMEl GaafaryMEl SayedAMThe cardenolide glycoside Acovenoside A affords protective activity in doxorubicin-induced cardiotoxicity in miceJ Pharmacol Exp Ther2016358226227027247000
  • MaSLiXDongLZhuJZhangHJiaYProtective effect of Sheng-Mai Yin, a traditional Chinese preparation, against doxorubicin-induced cardiac toxicity in ratsBMC Complement Altern Med2016166126865364
  • SpinaleFGCokerMLBondBRZellnerJLMyocardial matrix degradation and metalloproteinase activation in the failing heart: a potential therapeutic targetCardiovasc Res200046222523810773226
  • PolegatoBFMinicucciMFAzevedoPSAcute doxorubicin-induced cardiotoxicity is associated with matrix metalloproteinase-2 alterations in ratsCell Physiol Biochem20153551924193325871735
  • ZhangJMAnJCytokines, inflammation, and painInt Anesthesiol Clin2007452273717426506
  • ZhaoWZhaoTChenYAhokasRASunYOxidative stress mediates cardiac fibrosis by enhancing transforming growth factor-beta1 in hypertensive ratsMol Cell Biochem20083171–2435018581202
  • MorrowDACannonCPJesseRLNational academy of clinical biochemistry laboratory medicine practice guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromesCirculation200711513e356e37517384331
  • ShiYMoonMDawoodSMcManusBLiuPPMechanisms and management of doxorubicin cardiotoxicityHerz201136429630521656050
  • StěrbaMPopelováOVávrováAOxidative stress, redox signaling, and metal chelation in anthracycline cardiotoxicity and pharmacological cardioprotectionAntioxid Redox Signal201318889992922794198
  • RajSFrancoVILipshultzSEAnthracycline-induced cardiotoxicity: a review of pathophysiology, diagnosis, and treatmentCurr Treat Options Cardiovasc Med2014166114
  • ZhaoYMiriyalaSMiaoLRedox proteomic identification of HNE-bound mitochondrial proteins in cardiac tissues reveals a systemic effect on energy metabolism after doxorubicin treatmentFree Radic Biol Med201472556524632380
  • SinghPSharmaRMcElhanonKSulforaphane protects the heart from doxorubicin-induced toxicityFree Radic Biol Med2015869010126025579
  • YarmohmmadiFRahimiNFaghir-GhanesefatHProtective effects of agmatine on doxorubicin-induced chronic cardiotoxicity in ratEur J Pharmacol2017796394427993640
  • HuiBYaoXZhouQWuZShengPZhangLPristimerin, a natural anti-tumor triterpenoid, inhibits LPS-induced TNF-α and IL-8 production through down-regulation of ROS-related classical NF-kB pathway in THP-1 cellsInt Immunopharmacol201421250150824957686
  • JohnsonGLLapadatRMitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinasesScience200229856001911191212471242
  • DasJGhoshJMannaPSilPCTaurine suppresses doxorubicin-triggered oxidative stress and cardiac apoptosis in rat via up-regulation of PI3-K/Akt and inhibition of p53, p38-JNKBiochem Pharmacol201181789190921295553
  • GhoshJDasJMannaPSilPCThe protective role of arjunolic acid against doxorubicin induced intracellular ROS dependent JNK-p38 and p53-mediated cardiac apoptosisBiomaterials201132214857486621486680
  • XiaoJSunGBSunBKaempferol protects against doxorubicin-induced cardiotoxicity in vivo and in vitroToxicology20122921536222155320
  • JinYWangYZhaoDMaSLuJShuangGPristimerin attenuates ovalbumin-induced allergic airway inflammation in miceImmunopharmacol Immunotoxicol201638322122727098091
  • MukherjeeSBanerjeeSKMaulikMDindaAKTalwarKKMaulikSKProtection against acute adriamycin-induced cardiotoxicity by garlic: role of endogenous antioxidants and inhibition of TNF-alpha expressionBMC Pharmacol200331614687418
  • GuerraJDe JesusASantiago-BorreroPRoman-FrancoARodríguezECrespoMJPlasma nitric oxide levels used as an indicator of doxorubicin-induced cardiotoxicity in ratsHematol J20055758458815692604
  • DengSKrugerASchmidtADifferential roles of nitric oxide synthase isozymes in cardiotoxicity and mortality following chronic doxorubicin treatment in miceNaunyn Schmiedebergs Arch Pharmacol20093801253419308358
  • MukhopadhyayPRajeshMBátkaiSRole of superoxide, nitric oxide, and peroxynitrite in doxorubicin-induced cell death in vivo and in vitroAm J Physiol Heart Circ Physiol20092965H1466H148319286953
  • MorganMJLiuZGCrosstalk of reactive oxygen species and NF-kB signalingCell Res201121110311521187859